Data quality, governance and sharing to enable insights and decision-making


Scientific and technological advancements in recent decades have fundamentally transformed clinical trials through digitisation and innovation in trial design and implementation. This has given rise to a new data normal where the volume, velocity, and variety of data are continually increasing, and this new landscape demands modern and robust data management practices for governance, personnel, processes, and technology. This raises the question of how industry and regulators adapt data management and governance to keep pace. A proactive approach to managing associated risks will help regulators accept data. This paper provides a comprehensive picture of the digital revolution in clinical trials, including relevant regulatory developments, while highlighting the opportunity to enhance drug development’s efficiency, accuracy, and cost-effectiveness.

How to read this journal article 

Thank you for visiting Regulatory Rapporteur. Journal articles are restricted to registered users and TOPRA members.

Already a member or have an account? Sign in.


Free access to selected content

Register now to continue to access industry news, editorials and podcasts plus one member-only journal article each month.

  • Create your own library to save your favourite content.
Create a free account

2. Members login

Already a TOPRA member?

Log-in now using your MyTOPRA credentials, for unlimited access to all Regulatory Rapporteur journal articles, the online archive and latest industry news and podcasts.



Special offer on
TOPRA membership

Join TOPRA today and get membership until the end of 2025 for the exclusive rate of £290.

In addition to unlimited access to Regulatory Rapporteur content, as a TOPRA member you will also be able to enjoy a wide range of benefits including career boosting resources, savings on our events and training, and access to our regional networks and special interest groups.

This offer ends 31 July 2024

Become a member